Yeast expressed cytochrome P450 2D6 (CYP2D6) exposed on the external face of plasma membrane is functionally competent

被引:29
|
作者
Loeper, J [1 ]
Louérat-Oriou, B [1 ]
Duport, C [1 ]
Pompon, D [1 ]
机构
[1] Univ Paris 06, CNRS, Lab Propre Associe, Ctr Genet Mol, F-91198 Gif Sur Yvette, France
关键词
D O I
10.1124/mol.54.1.8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
CYP2D6, a xenobiotic metabolizing cytochrome P450 (P450), was found to be present in significant amount on the outer face of cell plasma membrane in addition to the regular microsomal location. Present work demonstrates that this external P450 is catalytically competent and that activity is supported by NADPH-P450 reductase present on the inner face of plasma membrane. Purified plasma membranes from yeast expressing CYP2D6 sustained NADPH- and cumene hydroperoxide-dependent dextromethorphan demethylation and NADPH-cytochrome c activity confirming previous observations in human hepatocytes. CYP2D6 found on the outside of plasma membrane (by differential immune-inhibition and acidic shift assays on transformed spheroplasts) was catalytically competent at the cell surface for NADPH-supported activities. Anti-yeast P450-reductase antibodies inhibited neither CYP2D6 nor P450-reductase activities upon incubation with intact spheroplasts. In contrast, both activities were inhibited on isolated plasma membrane fragments. This highly suggested a cytosolic-orientation of the plasma membrane P450-reductase. This finding was confirmed by immunostaining in confocal microscopy. Finally, gene deletion of P450-reductase caused a complete loss of plasma membrane NADPH-supported CYP2D6 activity, which suggests that the reductase participates to some degree in the transmembrane electron transfer chain. This work illustrates that the outside-exposed plasma membrane CYP2D6 is active and may play an important metabolic role.
引用
收藏
页码:8 / 13
页数:6
相关论文
共 50 条
  • [1] INHIBITION OF HUMAN CYTOCHROME P450 2D6 (CYP2D6) BY METHADONE
    WU, D
    OTTON, SV
    SPROULE, BA
    BUSTO, U
    INABA, T
    KALOW, W
    SELLERS, EM
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 35 (01) : 30 - 34
  • [2] GENETIC POLYMORPHISM IN CYTOCHROME P450 2D6 (CYP2D6): POPULATION DISTRIBUTION OF CYP2D6 ACTIVITY
    Neafsey, Patricia
    Ginsberg, Gary
    Hattis, Dale
    Sonawane, Babasaheb
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS, 2009, 12 (5-6): : 334 - 361
  • [3] Functional Characterization of Cytochrome P450 2D6 (CYP2D6) Allelic Variant CYP2D6*10
    Dong, A. N.
    Ong, C. E.
    Pan, Y.
    Palanisamy, U. D.
    Ismail, R.
    PUBLIC HEALTH GENOMICS, 2015, 18 : 49 - 49
  • [4] Cytochrome p450 2D6 (CYP2D6) inhibitory constituents of Catharanthus roseus
    Usia, T
    Watabe, T
    Kadota, S
    Tezuka, Y
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2005, 28 (06) : 1021 - 1024
  • [5] Dose dependency of dextromethorphan for cytochrome P450 2D6 (CYP2D6) phenotyping
    Streetman, DS
    Ellis, RE
    Nafziger, AN
    Leeder, JS
    Gaedigk, A
    Gotschall, R
    Kearns, GL
    Bertino, JS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 66 (05) : 535 - 541
  • [6] Cytochrome P450 2D6 (CYP2D6) activity in relation to the antitussive effect of dextromethorphan
    Abdul-Manap, R
    Wright, CE
    Rostami-Hodjegan, A
    Meller, S
    Lennard, MS
    Morice, AH
    Tucker, GT
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 47 (05) : 586 - 587
  • [7] A longitudinal study of cytochrome P450 2D6 (CYP2D6) activity during adolescence
    Leeder, J. Steven
    Gaedigk, Andrea
    Wright, Krista J.
    Staggs, Vincent S.
    Soden, Sarah E.
    Lin, Yvonne S.
    Pearce, Robin E.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 15 (10): : 2514 - 2527
  • [8] Cytochrome P450 2D6 and schizophrenia.: Is the frequent CYP2D6*2 allele protective?
    Meary, A.
    Loriot, M. A.
    Brousse, G.
    Szoke, A.
    Schurhoff, F.
    Lancon, C.
    Llorca, P. M.
    Broly, F.
    Beaune, P.
    Leboyer, M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 56 - 56
  • [9] Metabolomics reveals biomarkers in human urine and plasma to predict cytochrome P450 2D6 (CYP2D6) activity
    Magliocco, Gaelle
    Desmeules, Jules
    Matthey, Alain
    Quiros-Guerrero, Luis M.
    Bararpour, Nasim
    Joye, Timothee
    Marcourt, Laurence
    Queiroz, Emerson F.
    Wolfender, Jean-Luc
    Gloor, Yvonne
    Thomas, Aurelien
    Daali, Youssef
    BRITISH JOURNAL OF PHARMACOLOGY, 2021, 178 (23) : 4708 - 4725
  • [10] Cytochrome P450 2D6
    Owen, Ryan P.
    Sangkuhl, Katrin
    Klein, Teri E.
    Altman, Russ B.
    PHARMACOGENETICS AND GENOMICS, 2009, 19 (07): : 559 - 562